| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.001 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.17 | 0.003 |